ark health tirzepatide How the weight loss drug is also helping heart failure patients Mounjaro - Ark Health

Potential candidates for medical weight loss at Klinic include adults with a BMI of 30 or higher, or 27-plus with other weight-related conditions

Parker JC, Berkowitz LR

Guidance Was on the Cautious Side Teva issued its 2025 full-year preliminary guidance for EPS of $2.35 to $2.65 versus $2.78 consensus estimates

Finding reputable suppliers requires research into third-party testing, community reputation, and verified purity certificates

Given that obesity is associated with so many other health problems, we can expect that the pharmaceutical companies will seek a similar, wonderdrug blessing from the FDA for the GLP-1s ability to improve cardiovascular diseases